Julia Hallisey

Julia Hallisey is the Chief Operating Officer and Director of Investor Relations at Asha Therapeutics, a life sciences company specializing in designing compounds for various diseases. Julia also held similar roles at Ibis Therapeutics, Venn Therapeutics, and Proclaim, showcasing their expertise in strategy, finance, and corporate development. With a background in investor relations and analytics, Julia has positioned multiple companies for sustainable growth. Julia holds a Master of Business Administration from Harvard Business School and a Bachelor of Arts in English Language and Literature from Smith College.